PGIMER increases sponsored seats for MD, MS, DM courses

Published On 2023-10-11 09:51 GMT   |   Update On 2023-10-11 09:51 GMT

In a significant move, the Post Graduate Institute of Medical Education and Research (PGIMER) / PGI Chandigarh has greenlit a proposal to substantially increase the number of sponsored seats available for MD, MS, and DM courses. The decision effectively doubles the sponsored seat quota, elevating it from 45 to 88.Sponsored candidates are primarily government employees, notably including...

Login or Register to read the full article

In a significant move, the Post Graduate Institute of Medical Education and Research (PGIMER) / PGI Chandigarh has greenlit a proposal to substantially increase the number of sponsored seats available for MD, MS, and DM courses. The decision effectively doubles the sponsored seat quota, elevating it from 45 to 88.

Sponsored candidates are primarily government employees, notably including defence personnel, with a prerequisite of a minimum of three years of service. Upon obtaining a no-objection certificate (NOC) from their parent department, sponsored candidates can seek admission to the desired medical course, and during their academic pursuit, their department sponsors their salary. The move holds particular importance for defence personnel aspiring to attain super-specialty qualifications.

For more details, check out the link given below:

PGI Chandigarh Increases Sponsored Seats For MD, MS, DM Courses From 45 To 88


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News